Moreover, when we analyzed an OCT4/SOX2/NANOG stem cell gene signature previously characterized by Boyer et al.[11] in independent publicly available NSCLC datasets, the signature was found to effectively discriminate both major NSCLC subtypes. This evidence concerns the gene SOX2 and non-small cell lung carcinoma.